These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 18172099)

  • 1. Drug modification of angiogenesis in a rat cornea model.
    Schwartz S; George J; Ben-Shoshan J; Luboshits G; Avni I; Levkovitch-Verbin H; Ziv H; Rosner M; Barak A
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):250-4. PubMed ID: 18172099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of corneal angiogenesis by local application of vasostatin.
    Wu PC; Yang LC; Kuo HK; Huang CC; Tsai CL; Lin PR; Wu PC; Shin SJ; Tai MH
    Mol Vis; 2005 Jan; 11():28-35. PubMed ID: 15660022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model of angiogenesis in the mouse cornea.
    Kenyon BM; Voest EE; Chen CC; Flynn E; Folkman J; D'Amato RJ
    Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1625-32. PubMed ID: 8675406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human epidermal growth factor and corneal neovascularization.
    Nezu E; Ohashi Y; Kinoshita S; Manabe R
    Jpn J Ophthalmol; 1992; 36(4):401-6. PubMed ID: 1289616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis effects of nerve growth factor (NGF) on rat corneas.
    Seo K; Choi J; Park M; Rhee C
    J Vet Sci; 2001 Aug; 2(2):125-30. PubMed ID: 14614283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombospondin and in vivo angiogenesis induced by basic fibroblast growth factor or lipopolysaccharide.
    BenEzra D; Griffin BW; Maftzir G; Aharonov O
    Invest Ophthalmol Vis Sci; 1993 Dec; 34(13):3601-8. PubMed ID: 8258518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of rat corneal angiogenesis by 16-kDa prolactin and by endogenous prolactin-like molecules.
    Dueñas Z; Torner L; Corbacho AM; Ochoa A; Gutiérrez-Ospina G; López-Barrera F; Barrios FA; Berger P; Martínez de la Escalera G; Clapp C
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2498-505. PubMed ID: 10509642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis inhibition and choroidal neovascularization suppression by sustained delivery of an integrin antagonist, EMD478761.
    Fu Y; Ponce ML; Thill M; Yuan P; Wang NS; Csaky KG
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5184-90. PubMed ID: 17962472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mouse cornea micropocket angiogenesis assay.
    Rogers MS; Birsner AE; D'Amato RJ
    Nat Protoc; 2007; 2(10):2545-50. PubMed ID: 17947997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose response of angiogenesis to basic fibroblast growth factor in rat corneal pocket assay: I. Experimental characterizations.
    Tong S; Yuan F
    Microvasc Res; 2008 Jan; 75(1):10-5. PubMed ID: 17706726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of fibroblast activation proteins in corneal stromal neovascularization.
    Wang T; Shi W
    Curr Eye Res; 2009 Feb; 34(2):112-7. PubMed ID: 19219682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of experimental angiogenesis of cornea by various doses of doxycycline and combination of triamcinolone acetonide with low-molecular-weight heparin and doxycycline.
    Aydin E; Kivilcim M; Peyman GA; Esfahani MR; Kazi AA; Sanders DR
    Cornea; 2008 May; 27(4):446-53. PubMed ID: 18434849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel vector system for gene transfer into the cornea using a partially dried plasmid expressing 18 basic fibroblast growth factor-synthetic amphiphile INTeraction-18 (SAINT-18) complex.
    Kuo CN; Yang LC; Yang CT; Chen MF; Lai CH; Chen YH; Chen CH; Chen CH; Wu PC; Kou HK; Tsai JC; Hung CH
    Curr Eye Res; 2008 Oct; 33(10):839-48. PubMed ID: 18853317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of antiglaucoma drugs on collagen gel contraction mediated by human corneal fibroblasts.
    Liu Y; Yanai R; Lu Y; Hirano S; Sagara T; Nishida T
    J Glaucoma; 2006 Jun; 15(3):255-9. PubMed ID: 16778650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of topical antiglaucoma medications on corneal epithelium as evaluated by gene expression patterns.
    Okada Y
    Cornea; 2007 Oct; 26(9 Suppl 1):S46-54. PubMed ID: 17881916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose response of angiogenesis to basic fibroblast growth factor in rat corneal pocket assay: II. Numerical simulations.
    Tong S; Yuan F
    Microvasc Res; 2008 Jan; 75(1):16-24. PubMed ID: 18031768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of corneal neovascularization: evaluation of various commercially available compounds in an experimental rat model.
    Riazi-Esfahani M; Peyman GA; Aydin E; Kazi AA; Kivilcim M; Sanders DR
    Cornea; 2006 Aug; 25(7):801-5. PubMed ID: 17068457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoption of new antiglaucoma drugs in Finland: impact of changes in copayment.
    Martikainen JE; Häkkinen U; Enlund H
    Clin Ther; 2007 Nov; 29(11):2468-76. PubMed ID: 18158088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.
    Nixon DR; Yan DB; Chartrand JP; Piemontesi RL; Simonyi S; Hollander DA
    Curr Med Res Opin; 2009 Jul; 25(7):1645-53. PubMed ID: 19476406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term effect of topical dorzolamide hydrochloride on intrastromal corneal pressure in rabbit corneas in vivo.
    Teus MA; Bolívar G; Alió JL; Lipshitz I
    Cornea; 2009 Feb; 28(2):206-10. PubMed ID: 19158566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.